Dyadic International Inc (DYAI)
1.65
-0.01
(-0.60%)
USD |
NASDAQ |
May 17, 16:00
1.66
+0.01
(+0.61%)
After-Hours: 20:00
Dyadic International Cash from Operations (TTM): -5.653M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -5.653M |
December 31, 2023 | -6.727M |
September 30, 2023 | -7.485M |
June 30, 2023 | -7.300M |
March 31, 2023 | -7.420M |
December 31, 2022 | -8.084M |
September 30, 2022 | -9.037M |
June 30, 2022 | -11.60M |
March 31, 2022 | -12.22M |
December 31, 2021 | -11.28M |
September 30, 2021 | -9.929M |
June 30, 2021 | -6.978M |
March 31, 2021 | -6.485M |
December 31, 2020 | -6.574M |
September 30, 2020 | -6.688M |
June 30, 2020 | -6.846M |
March 31, 2020 | -6.370M |
December 31, 2019 | -5.783M |
September 30, 2019 | -5.611M |
June 30, 2019 | -4.871M |
March 31, 2019 | -5.156M |
December 31, 2018 | -4.407M |
September 30, 2018 | -4.339M |
June 30, 2018 | -5.232M |
March 31, 2018 | -1.602M |
Date | Value |
---|---|
December 31, 2017 | -1.691M |
September 30, 2017 | -2.027M |
June 30, 2017 | -4.649M |
March 31, 2017 | -4.637M |
December 31, 2016 | -6.032M |
September 30, 2016 | -7.253M |
June 30, 2016 | -1.559M |
March 31, 2016 | -2.042M |
December 31, 2015 | -0.8027M |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
March 31, 2014 | 3.120M |
December 31, 2013 | 5.096M |
September 30, 2013 | 5.146M |
June 30, 2013 | 2.729M |
March 31, 2013 | -0.6381M |
September 30, 2012 | 8.099M |
June 30, 2012 | 6.610M |
March 31, 2012 | 3.093M |
December 31, 2006 | 0.7905M |
September 30, 2006 | -9.665M |
June 30, 2006 | -9.300M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-12.22M
Minimum
Mar 2022
-4.871M
Maximum
Jun 2019
-7.647M
Average
-6.912M
Median
Cash from Operations (TTM) Benchmarks
AIM ImmunoTech Inc | -21.27M |
Perspective Therapeutics Inc | -13.34M |
Protalix BioTherapeutics Inc | 5.868M |
Electromed Inc | 5.577M |
Armata Pharmaceuticals Inc | -40.44M |